Jump to:

Latest site updates

New drugs

  • Valdoxan – melatonergic agonist for the treatment of depression
  • PhosLo – new phosphate binder for managing hyperphosphataemia

List of deleted products

Discover more features of the new MIMS website on the About MIMS page and please send your feedback and ideas to mims@haymarket.com

MIMS News

Valdoxan

Servier has launched Valdoxan (agomelatine) for the treatment of major depressive episodes...

 

BuTrans in moderate chronic pain

BuTrans ( buprenorphine ) patches are now indicated in the management of...

 

Diovan for heart failure

The angiotensin II antagonist Diovan (valsartan) is now licensed for the treatment...

 

Interaction between clopidogrel and PPIs

The EU Committee for Medicinal Products for Human Use (CHMP) has stated...

 

Glivec licence extension

The licence for Glivec (imatinib) has been extended to include its use...

 

PhosLo

PhosLo (calcium acetate) is a new phosphate binder available for the prevention...

 

Deleted products

The following products were discontinued from the UK market during 2009. The list...

 

Qlaira

Bayer has launched Qlaira, the first combined oral contraceptive to use estradiol...

 

Firmagon

Degarelix is the first gonadotrophin releasing-hormone (GnRH) antagonist licensed for use in...

 

Extavia

A new interferon beta-1b available for the management of multiple sclerosis.

 

Latest MIMS Publications

MIMS monthly

Click to find out more

  • July 2009
  • Over 200 updates
  • New drug review
  • List of new and deleted products

MIMS for Nurses

Click to find out more

  • Independent Prescriber Formulary December 2008
  • Over 1200 updates
  • Fourteen new drug reviews
  • Visual guides for respiratory and diabetes devices
 

MIMs Drug Search

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.

Find drugs by:

 

Back to top